Journal article
Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
- Abstract:
- The aim of the present review is to analyze how thinking about the cardiovascular safety of nonsteroidal antiinflammatory drugs has evolved during the past two decades, and discuss to what extent the additional information from the Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen study may alter our current mechanistic understanding and/or clinical practice.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Medical Research Council
More from this funder
British Heart Foundation
More from this funder
Bibliographic Details
- Publisher:
- American Society for Clinical Pharmacology and Therapeutics Publisher's website
- Journal:
- Clinical Pharmacology and Therapeutics Journal website
- Volume:
- 102
- Issue:
- Heart Failure
- Pages:
- 238–245
- Publication date:
- 2017-05-26
- Acceptance date:
- 2017-03-15
- DOI:
- EISSN:
-
1532-6535
- ISSN:
-
0009-9236
- Source identifiers:
-
689450
Item Description
- Language:
- English
- Pubs id:
-
pubs:689450
- UUID:
-
uuid:0089b8a5-b8d2-446b-80f3-efef789cef70
- Local pid:
- pubs:689450
- Deposit date:
- 2017-04-20
Terms of use
- Copyright holder:
- American Society for Clinical Pharmacology and Therapeutics
- Copyright date:
- 2017
- Notes:
- Copyright © 2017 American Society for Clinical Pharmacology and Therapeutics. This is the accepted manuscript version of the article. The final version is available online from American Society for Clinical Pharmacology and Therapeutics at: https://doi.org/10.1002/cpt.696
If you are the owner of this record, you can report an update to it here: Report update to this record